166 related articles for article (PubMed ID: 23073704)
21. Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF.
Knowles HJ; Athanasou NA
J Pathol; 2008 May; 215(1):56-66. PubMed ID: 18283716
[TBL] [Abstract][Full Text] [Related]
22. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway.
Carroll VA; Ashcroft M
Cancer Res; 2006 Jun; 66(12):6264-70. PubMed ID: 16778202
[TBL] [Abstract][Full Text] [Related]
23. GM-CSF induces expression of soluble VEGF receptor-1 from human monocytes and inhibits angiogenesis in mice.
Eubank TD; Roberts R; Galloway M; Wang Y; Cohn DE; Marsh CB
Immunity; 2004 Dec; 21(6):831-42. PubMed ID: 15589171
[TBL] [Abstract][Full Text] [Related]
24. Granulocyte macrophage colony-stimulating factor inhibits breast cancer growth and metastasis by invoking an anti-angiogenic program in tumor-educated macrophages.
Eubank TD; Roberts RD; Khan M; Curry JM; Nuovo GJ; Kuppusamy P; Marsh CB
Cancer Res; 2009 Mar; 69(5):2133-40. PubMed ID: 19223554
[TBL] [Abstract][Full Text] [Related]
25. Renal cancer cells lacking hypoxia inducible factor (HIF)-1alpha expression maintain vascular endothelial growth factor expression through HIF-2alpha.
Shinojima T; Oya M; Takayanagi A; Mizuno R; Shimizu N; Murai M
Carcinogenesis; 2007 Mar; 28(3):529-36. PubMed ID: 16920734
[TBL] [Abstract][Full Text] [Related]
26. Hypoxia-induced, perinecrotic expression of endothelial Per-ARNT-Sim domain protein-1/hypoxia-inducible factor-2alpha correlates with tumor progression, vascularization, and focal macrophage infiltration in bladder cancer.
Onita T; Ji PG; Xuan JW; Sakai H; Kanetake H; Maxwell PH; Fong GH; Gabril MY; Moussa M; Chin JL
Clin Cancer Res; 2002 Feb; 8(2):471-80. PubMed ID: 11839666
[TBL] [Abstract][Full Text] [Related]
27. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
28. HIF-1α and HIF-2α induced angiogenesis in gastrointestinal vascular malformation and reversed by thalidomide.
Feng N; Chen H; Fu S; Bian Z; Lin X; Yang L; Gao Y; Fang J; Ge Z
Sci Rep; 2016 Jun; 6():27280. PubMed ID: 27249651
[TBL] [Abstract][Full Text] [Related]
29. Microvasculopathic neuromuscular diseases: lessons from hypoxia-inducible factors.
Probst-Cousin S; Neundörfer B; Heuss D
Neuromuscul Disord; 2010 Mar; 20(3):192-7. PubMed ID: 20122829
[TBL] [Abstract][Full Text] [Related]
30. Cooperative interaction of hypoxia-inducible factor-2alpha (HIF-2alpha ) and Ets-1 in the transcriptional activation of vascular endothelial growth factor receptor-2 (Flk-1).
Elvert G; Kappel A; Heidenreich R; Englmeier U; Lanz S; Acker T; Rauter M; Plate K; Sieweke M; Breier G; Flamme I
J Biol Chem; 2003 Feb; 278(9):7520-30. PubMed ID: 12464608
[TBL] [Abstract][Full Text] [Related]
31. Cell-permeable iron inhibits vascular endothelial growth factor receptor-2 signaling and tumor angiogenesis.
Kir D; Saluja M; Modi S; Venkatachalam A; Schnettler E; Roy S; Ramakrishnan S
Oncotarget; 2016 Oct; 7(40):65348-65363. PubMed ID: 27589831
[TBL] [Abstract][Full Text] [Related]
32. Targeting both HIF-1 and HIF-2 in human colon cancer cells improves tumor response to sunitinib treatment.
Burkitt K; Chun SY; Dang DT; Dang LH
Mol Cancer Ther; 2009 May; 8(5):1148-56. PubMed ID: 19435875
[TBL] [Abstract][Full Text] [Related]
33. Myocardial hypertrophy overrides the angiogenic response to hypoxia.
Choi YH; Cowan DB; Nathan M; Poutias D; Stamm C; del Nido PJ; McGowan FX
PLoS One; 2008; 3(12):e4042. PubMed ID: 19112498
[TBL] [Abstract][Full Text] [Related]
34. Role of hypoxia-inducible factor 1alpha in gastric cancer cell growth, angiogenesis, and vessel maturation.
Stoeltzing O; McCarty MF; Wey JS; Fan F; Liu W; Belcheva A; Bucana CD; Semenza GL; Ellis LM
J Natl Cancer Inst; 2004 Jun; 96(12):946-56. PubMed ID: 15199114
[TBL] [Abstract][Full Text] [Related]
35. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
[TBL] [Abstract][Full Text] [Related]
36. Hypoxia inducible factors 1alpha and 2alpha are associated with VEGF expression and angiogenesis in gallbladder carcinomas.
Giatromanolaki A; Sivridis E; Simopoulos C; Polychronidis A; Gatter KC; Harris AL; Koukourakis MI
J Surg Oncol; 2006 Sep; 94(3):242-7. PubMed ID: 16900513
[TBL] [Abstract][Full Text] [Related]
37. Regulation of the HIF-system in human macrophages--differential regulation of HIF-α subunits under sustained hypoxia.
Poitz DM; Augstein A; Hesse K; Christoph M; Ibrahim K; Braun-Dullaeus RC; Strasser RH; Schmeißer A
Mol Immunol; 2014 Feb; 57(2):226-35. PubMed ID: 24176785
[TBL] [Abstract][Full Text] [Related]
38. The peptidyl prolyl isomerase, PIN1 induces angiogenesis through direct interaction with HIF-2α.
Choi MA; Saeidi S; Han HJ; Kim SJ; Kwon N; Kim DH; Min SH; Choi BY; Surh YJ
Biochem Biophys Res Commun; 2020 Dec; 533(4):995-1003. PubMed ID: 33012513
[TBL] [Abstract][Full Text] [Related]
39. Endothelin-1 regulates hypoxia-inducible factor-1α and -2α stability through prolyl hydroxylase domain 2 inhibition in human lymphatic endothelial cells.
Caprara V; Scappa S; Garrafa E; Di Castro V; Rosanò L; Bagnato A; Spinella F
Life Sci; 2014 Nov; 118(2):185-90. PubMed ID: 24607784
[TBL] [Abstract][Full Text] [Related]
40. Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hypoxic conditions.
Chae KS; Kang MJ; Lee JH; Ryu BK; Lee MG; Her NG; Ha TK; Han J; Kim YK; Chi SG
Oncogene; 2011 Mar; 30(10):1213-28. PubMed ID: 21057546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
